Objectives To identify MRI biomarkers associated with long-term disability progression in
patients with multiple sclerosis (MS), and to define the rate of evolution of global, tissue …

Background Cardiovascular (CV) risk factors have been associated with changes in clinical
outcomes in patients with multiple sclerosis (MS). Objectives To investigate the frequency of …

Magnetic resonance imaging (MRI) is the most important paraclinical measure for assessing
and monitoring the pathologic changes implicated in the onset and progression of multiple …

Background: Leptomeningeal contrast enhancement (LM CE) has been recently described
in multiple sclerosis (MS) patients as a potential in vivo marker of cortical pathology …

Background: We explored the evolution of brain atrophy in relation to development of
confirmed disability progression (CDP) on serial 1.5 T magnetic resonance imaging (MRI) …

Background: Cognitive decline is characterized in multiple sclerosis (MS), but the rate and
severity vary. The reserve hypothesis proposes that baseline neurological differences …

Purpose To assess cerebral microbleed (CMB) prevalence in patients with multiple sclerosis
(MS) and clinically isolated syndrome (CIS) and associations with clinical outcomes …

To determine whether jugular venous reflux (JVR) is associated with cerebral white matter
changes (WMCs) in individuals with Alzheimer's disease (AD), we studied 12 AD patients 24 …

ABSTRACT BACKGROUND AND PURPOSE Lesion accrual in multiple sclerosis (MS) is an
important and clinically relevant measure, used extensively as an imaging trial endpoint …

Background Atrophied T2 lesion volume at MRI is an imaging measure that reflects the
replacement of T2 lesions by cerebrospinal fluid spaces in patients with multiple sclerosis …